bopindolol has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goa, KL; Harron, DW; Langtry, HD | 1 |
| Nieminen, MS; Pellinen, TJ; Rapola, JM; Toivonen, L | 1 |
| Mérier, G; Ratib, O; Righetti, A; Rutishauser, W; Viquerat, C | 1 |
1 review(s) available for bopindolol and Coronary Disease
| Article | Year |
|---|---|
Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Coronary Disease; Half-Life; Hemodynamics; Humans; Hypertension; Kidney; Pindolol; Tissue Distribution | 1991 |
1 trial(s) available for bopindolol and Coronary Disease
| Article | Year |
|---|---|
Haemodynamic effects of bopindolol and atenolol in coronary artery disease. A noninvasive study.
Topics: Atenolol; Blood Pressure; Cardiac Output; Coronary Disease; Double-Blind Method; Echocardiography; Heart Rate; Hemodynamics; Humans; Pindolol | 1990 |
1 other study(ies) available for bopindolol and Coronary Disease
| Article | Year |
|---|---|
Effects of bopindolol on left ventricular function during exercise in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Coronary Disease; Heart; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Physical Exertion; Pindolol; Rest; Stroke Volume | 1986 |